News

Merz acquires Cuvposa

BY Allison Cerra

GREENSBORO, N.C. — Merz announced it has acquired a medication designed to treat a condition associated with such neurologic conditions as cerebral palsy.

The company said it acquired Cuvposa (glycopyrrolate) oral solution from drug maker Shionogi. Cuvposa, which has been commercially available since April 2011, is the only Food and Drug Administration-approved treatment to reduce chronic severe drooling — a condition known as sialorrhea — in pediatric patients ages 3 to 16 years with neurologic conditions associated with problem drooling, such as cerebral palsy.

"The acquisition of Cuvposa is a promising addition to our neurology business and reflects our commitment to becoming a recognized leader in the treatment of movement disorders and related conditions in the U.S.," Merz president and CEO Bill Humphries said. "Globally, the Merz Pharma Group is deeply committed to offering novel therapeutic options that address the large unmet medical needs that exists within the areas of central nervous system and neurology."


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Perrigo, Tris Pharma launch generic cough-cold product

BY Allison Cerra

ALLEGAN, Mich., and MONMOUTH JUNCTION, N.J. — Perrigo and Tris Pharma have launched a private-label version of Delsym extended-release oral liquid suspension containing dextromethorphan polistirex.

The comapnies said the product, which is indicated for the temporary treatment of cough due to minor throat and bronchial irritation, will be marketed under major U.S. retailer and wholesalers’ store brands or own label brands.

"We are excited to partner with Tris Pharma and bring this first ever store-brand extended-release liquid cough-cold product to our retail and store brand customers’ portfolios in time for the season," Perrigo president and CEO Joseph Papa said. "This launch continues to demonstrate our commitment to making quality healthcare more affordable for consumers."


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Omron hits stride with new pedometers

BY Allison Cerra

BANNOCKBURN, Ill. — Omron Healthcare has expanded its portfolio with the launch of its latest pedometers.

The Omron HJ-320 pedometer is an easy-to-use motivational tool. The pedometer features Omron Tri-Axis technology, which accurately and quietly counts users’ steps; an automatic reset; a weekly log, which stores up to seven days of information in memory and also includes two tracking modes: steps and distance.

The Omron HJ-321 pedometer, specifically designed for power walking, clips to one’s hip and tracks aerobic steps separately from walking steps. The pedometers features Omron Tri-Axis technology; an automatic reset; a weekly log, which stores up to seven days of information in memory and also includes four tracking modes: steps, aerobic "brisk" steps, calories and daily distance.

The HJ-320 pedometer carries a suggested retail price of $22.99 and is available at select sporting goods stores and pharmacies, while the Omron HJ-321 pedometer carries a suggested retail price of $26.99 and is available online.


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?